期刊文献+

血清乙型肝炎病毒DNA阳性与原发性肝癌危险性关系的前瞻性队列研究 被引量:10

A prospective study of the relationship between serum hepatitis B virus DNA and the risk of primary liver cancer
原文传递
导出
摘要 目的探讨血清HBV DNA阳性与原发性肝癌的关系。方法以分层抽样方法对广西隆安县12个乡镇30~55岁农村居民抽样,采静脉血,酶联免疫吸附试验检测HBsAg,套式聚合酶链反应检测HBV DNA。根据HBsAg和DNA检测结果,将研究对象分为HBsAg(+)/HBvDNA(+)组(A组)和HBsAg(+)/HBVDNA(-)组(B组);根据1:1匹配原则,从本村屯HBsAg(-)者中为前两组观察对象挑选对照,组成HBsAg阴性对照组(C组),对这3组人群进行4年的前瞻性跟踪随访。卡方检验对各组及各因素的发病率进行统计分析,然后用Cox比例风险模型分析与PLC有关的危险因素,用后退法对数值进行迭代分析。结果30~55岁人群HBsAg阳性率为14.52%(3975/27379),HBsAg阳性者HBV DNA阳性率为40.35%(1604/3975)。A、B两组总的肝癌发病率为672.45/10万人年,明显高于C组的17.19/10万人年(P〈0.01),相对危险度为39.123,95%可信因司为9.018~159.146。A组肝癌发病率为984.03/10万人年,显明高于C组的324.38/10万人年(P〈0.01),相对危险度为3.034,95%可信区间为1.795~5.125。对A、B两组进行肝癌危险因素的多因素Cox模型分析,结果表明性别、年龄、血清HBV DNA阳性、肝癌家族史和以玉米为主食均为肝癌的危险因素。结论血清HBV DNA阳性可增加HBsAg阳性者的肝癌危险性。 Objective To determine the relationship between the serum hepatitis B virus (HBV) DNA and the risk of primary liver cancer (PLC). Methods Farmers aged 30-55 years in Long An county were recruited in this study Blood samples were collected and the sera were tested for HBsAg using Enzyme- Linked ImmunoSorbent Assay (ELISA), and the HBsAg-positive sera were further tested for viral DNA using nested polymerase chain reaction (nPCR). The study subjects were divided into three groups. The first group was positive for both HBsAg and HBV DNA. The second group was positive for HBsAg but negative for HBV DNA. Age-, sex-, residence-matched HBsAg negative controls for group 1 and group 2 were enrolled in the third group. The cohort was followed up for four years. Results The positive rate of HBsAg in these farmers was 14.52% (3975/27 379), and the HBV DNA positive rate in HBsAg positive subjects was 40.35% (1604/3975). The total PLC incidence rate in Group 1 and 2 was 672.45/100 000 person-years (PY), significantly higher than that in Group3 (17.19/100 000 PY). The relative risk (RR) was 39.123, and the 95% confidence interval (CI) was 9.018-159.146. The PLC incidence rate of Group 1 (984.03/100 000 PY) was significantly higher than that of Group2 (324.38/100 000 PY). The RR was 3.034, and the 95% CI was 1.795-5.125. Multivariate analyses of Groupl and 2 with Cox model showed that sex, age, serum HBV DNA, and family history of PLC were independent risk factors of PLC. Conclusion HBV DNA and HBsAg positive subjects have a higher chance to develop PLC than HBV DNA negative-, HBsAg positive subjects.
出处 《中华肝脏病杂志》 CAS CSCD 北大核心 2009年第12期930-934,共5页 Chinese Journal of Hepatology
基金 英国Wellcome基金会资助项目(072058/Z/03/Z) 广西科学资金项目(桂科回0731005)
关键词 肝炎病毒 乙型 肝炎表面抗原 乙型 DNA 病毒 肝肿瘤 队列研究 前瞻性 Hepatitis B virus Hepatitis B surface antigens DNA, viral Liver neoplasms Prospective cohort study
  • 相关文献

参考文献14

  • 1McGlynu KA, London WT. Epidemiology and natural history of hepatocellular carcinoma. Best Pract Res Clin Gastroenterol, 2005, 19: 3-23.
  • 2Chart HL, Sung JJ. Hepatocellular carcinoma and hepatitis B virus. Semin Liver Dis, 2006, 26: 153-161.
  • 3Fang ZL, Yang J, Ge X, et al. Core promoter mutations (A(1762)T and G(1764)A) and viral genotype in chronic hepatitis B and hepatocellular carcinoma in Guangxi, China. J Med Virol, 2002, 68: 33- 40.
  • 4Ohata K, Hamasaki K, Toriyama K, et al. High viral load is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis B virus infection. J Gastroenterol Hepatol, 2004, 19: 670-675.
  • 5陈钦艳,董柏青,谭明杰,葛莲英,杨进业,韦少超,方孔雄,黄坚,李荣成,王学燕,Caroline Sabin,方钟燎,Tim J Harrison.隆安县乙型肝炎病毒感染的分子流行病学研究[J].应用预防医学,2007,13(3):142-145. 被引量:7
  • 6杨秉辉,夏景林.原发性肝癌的临床诊断与分期标准[J].中华肝脏病杂志,2001,9(6):324-324. 被引量:1013
  • 7Beasley RP. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer, 1988, 61: 1942-1956.
  • 8Yu MW, Yeh SH, Chen PJ, et al. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. J Natl Cancer Inst, 2005, 97: 265-272.
  • 9Tang B, Kruger WD, Chen G, et al. Hepatitis B viremia is associated with increased risk of hepatocellular carcinoma in chronic carriers. J Med Virol, 2004, 72: 35-40.
  • 10Liaw YF, Sung JJ, Chow WC, et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med, 2004, 351: 1521-1531.

二级参考文献10

  • 1杨进业,李荣成,王树声,龚健,李艳萍,陈琨琳,韦增良,李均伦,卓家同.广西五型病毒性肝炎流行病学调查[J].广西预防医学,1995,1(1):29-32. 被引量:24
  • 2广西自治区防疫站.广西乙型肝炎感染的分布[J].中华流行病学杂志,1982,3(2):84-84.
  • 3[1]Lesmana LA,Leung NW,Mahachai V,et al.Hepatitis B:overview of the burden of disease in the Asia-Pacific region[J].Liver Int,2006,26 (Suppl 2):3-10.
  • 4[2]Merican I,Guan R,Amarapuka D,et al.Chronic hepatitis B virus infection in Asian countries[J].J Gastroenterol Hepatol,2000,15(12):1356-1361.
  • 5[6]Liu CJ,Chen BF,Chen PJ,et al.Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers[J].J Infect Dis,2006,193(9):1258-1265.
  • 6[9]Silva Cde O,Azevedo Mda S,Soares CM,et al.Seroprevalence of hepatitis B virus infection in individuals with clinical evidence of hepatitis in Goiania,Goias.Detection of viral DNA and determination of subtypes[J].Rev Inst Med Trop Sao Paulo,2002,44(6):331-334.
  • 7[10]Chen DS,Lai MY,Lee SC,et al.Serum HBsAg,HBeAg,anti-HBe,and hepatitis B viral DNA in asymptomatic carriers in Taiwan[J].J Med Virol,1986,19(1):87-94.
  • 8吴引伟,刘新钰,臧桂珍.以HBV· DNA作为指标对HBV感染状态的调查研究[J].实用预防医学,1999,6(4):244-246. 被引量:3
  • 9梅起化.血清HBV-DNA检测临床意义的探讨[J].浙江中西医结合杂志,2003,13(7):426-427. 被引量:1
  • 10李荣成,杨进业,龚健,李艳萍,黄兆能,方孔雄,徐志一,刘崇柏,赵铠,庄辉.乙型肝炎疫苗接种预防乙型肝炎和肝癌效果[J].中华流行病学杂志,2004,25(5):385-387. 被引量:60

共引文献1017

同被引文献73

引证文献10

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部